We are live on ! Find out more
EPZM

Epizyme, Inc
EPZM

Delisted

EPZM was delisted on the 11th of August, 2022.

Back to rankings

0 hedge funds and large institutions have $4K invested in Epizyme, Inc in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 93 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 93 → 0 (-93)

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

100% less capital invested

Capital invested by funds: $187M → $4K (-$187M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 93

Holders
–
Holders Change
-93
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
93
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
RM
RP Management
New York
-$46.8M
2
Primecap Management
Primecap Management
California
-$24.5M
3
NM
Newtyn Management
New York
-$11.1M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$11.1M
5
RSCM
Rock Springs Capital Management
Maryland
-$11M
Name Holding Trade Value Shares
Change 		Change in
Stake
Two Sigma Investments
51
Two Sigma Investments
New York
– -$67K -45,316 Closed
TSS
52
Two Sigma Securities
New York
– -$65K -44,420 Closed
WS
53
Wedbush Securities
California
– -$63K -43,133 Closed
BFM
54
Boothbay Fund Management
New York
– -$37K -25,338 Closed
B
55
BP
United Kingdom
– -$363 -24,687 Closed
Verition Fund Management
56
Verition Fund Management
Connecticut
– -$34K -22,984 Closed
OQS
57
Occudo Quantitative Strategies
Florida
– -$33K -22,631 Closed
JRP
58
Jasper Ridge Partners
California
– -$32K -21,619 Closed
Teacher Retirement System of Texas
59
Teacher Retirement System of Texas
Texas
– -$30K -20,664 Closed
Squarepoint
60
Squarepoint
New York
– -$30K -20,509 Closed
HM
61
Harvest Management
New York
– -$29K -20,000 Closed
RPCA
62
Running Point Capital Advisors
California
– -$29K -20,000 Closed
SSA
63
Schonfeld Strategic Advisors
New York
– -$28K -18,600 Closed
Fidelity Investments
64
Fidelity Investments
Massachusetts
– -$27K -18,194 Closed
LPL Financial
65
LPL Financial
California
– -$26K -17,750 Closed
SB
66
Strategic Blueprint
Georgia
– -$25K -16,900 Closed
WJWM
67
Williams Jones Wealth Management
New York
– -$23K -15,555 Closed
Victory Capital Management
68
Victory Capital Management
Texas
– -$22K -15,287 Closed
PAG
69
Private Advisor Group
New Jersey
– -$22K -15,223 Closed
NSIM
70
North Star Investment Management
Illinois
– -$22K -15,000 Closed
CSS
71
Cubist Systematic Strategies
Connecticut
– -$19K -13,144 Closed
ProShare Advisors
72
ProShare Advisors
Maryland
– -$19K -12,840 Closed
TRCT
73
Tower Research Capital (TRC)
New York
– -$19K -12,427 Closed
BCI
74
Brinker Capital Investments
Pennsylvania
– -$16K -11,175 Closed
YIH
75
Y-Intercept (HK)
Hong Kong
– -$16K -10,697 Closed
1 2
3
4

EPZM Hedge Fund Activity: Q3 2022 in Review

0 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Epizyme, Inc (EPZM) for Q3 2022, worth a combined $4K — down 100% from $187M a quarter earlier.

Sellers outnumbered buyers: 93 funds closed out of EPZM and 0 opened new positions — a net loss of 93 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was RP Management, exiting entirely with an estimated $46.8M sold.

  • 0 institutional investors held Epizyme, Inc (EPZM) as of Q3 2022, down from 93 in Q2 2022.
  • Funds reported $4K of Epizyme, Inc stock for Q3 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Epizyme, Inc positions in Q3 2022 and 93 closed out, a net change of -93 holders.
  • The largest Epizyme, Inc seller in Q3 2022 was RP Management, an estimated $46.8M sold.

Based on aggregated 13F filings for Q3 2022.